Remove DEA Remove Policy Remove Presentation Remove Safety
article thumbnail

Cannabis Litigation: Second Circuit Could Force DEA to Re- or Deschedule Marijuana

Canna Law Blog

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Schedule I is reserved for drugs with a high potential for abuse, no currently accepted medical uses, and a lack of accepted safety for medical use. That one was granted.

DEA 97
article thumbnail

FDA and FTC Target Delta-8 Products

Canna Law Blog

But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. FTC Policy Statement on Deception, 103 F.T.C. For now, stay tuned to the Canna Law Blog for more updates on FDA and FTC cannabinoid policies and delta-8 products. You can read more about that issue here or here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Medical Cannabis Strains That Can be Used to Treat PTSD

FloridaMarijuana.net

One study presented by Multidisciplinary association for psychedelic studies specifically seeks veterans as participants in their medical marijuana project. MAPS worked for over 22 years to obtain marijuana for medical marijuana drug development research, and the approval is a historic shift in federal policy.

Strains 190
article thumbnail

Is your CBD what it says it is? Study finds high-THC weed sold as hemp

SpeedWeed

Presented By. As federal and state governments tackle the legalization of hemp as a distinct product from cannabis, the safety of the products produced from hemp isn’t getting the same attention as those produced from THC-based cannabis. March 31, 2021. This article was contributed by SC Labs, a Leafly Certified Labs partner.

THC 52
article thumbnail

Press Release: LegitScript Announces New CBD e-Commerce Certification Program to Ensure Accountability, Regulatory Compliance

Cannabis Law Report

Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript’s CEO, John Horton, said the program will bring transparency and structure to the CBD industry.

article thumbnail

Harvard Law Review: Patents on Psychedelics: The Next Legal Battlefront of Drug Development

Cannabis Law Report

The Essay presents proposals to reduce the risk of biopiracy and the issuance of unwarranted psychedelic patents. Controlled Substance Schedules , DRUG ENF’T ADMIN., [link] [ [link] ] (defining DEA criteria for categorization in Schedule I and listing psychedelic examples such as lysergic acid diethylamide (LSD), peyote, and MDMA).

article thumbnail

Memo to Congress: Fix the Farm Bill

Project CBD

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .” Safety The Problem with Percentages As mentioned earlier, the 0.3